Erin Bote

487 citations
12 papers · 366 · h-index 6

Impact in

  • Genetics top 10%
    • Virus-based gene therapy research
    • Neurogenetic and Muscular Disorders Research
    • Retinal Diseases and Treatments

Papers in

    • Virus-based gene therapy research 10
    • Retinal Development and Disorders 4
    • RNA Interference and Gene Delivery 3

Erin Bote

12 papers receiving 360 citations

Peers

Erin Bote
Comparison fields: 5 of 43
  • Genetics 211
  • Ophthalmology 34
  • Cellular and Molecular Neuroscience 68
  • Molecular Biology 232
  • Genetics 33
Replace Yoichiro Shinohara with:
Yoichiro Shinohara Japan
Peiyin Wang United States
Gwenaëlle Aurégan France
Kriti Mohan United States
Mira Malcov Israel
Kirsten E. Coleman United States
April R. Giles United States
Sandra Motas Spain
Filomena Tiziana Papa Italy
A.L. Taratuto Argentina
Erin Bote relative to Yoichiro Shinohara Japan Yoichiro Shinohara's profile →
Citations per field
00.5×4.1×
Yoichiro Shinohara · 1×
Citations per year

Countries citing papers authored by Erin Bote

Since Specialization
Citations

This map shows the geographic impact of Erin Bote's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erin Bote with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erin Bote more than expected).

Fields of papers citing papers by Erin Bote

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erin Bote. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erin Bote. The network helps show where Erin Bote may publish in the future.

Co-authors

The 25 scholars most cited alongside Erin Bote, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Erin Bote Line = papers co-authored together Erin Bote links everyone, so they are left out of the graph.

All Works

12 of 12 papers shown
#Work
1 2010112
2 2017100
3 2014100
4 201616
5 201814
6 201813
7 20155
8
Safety of the Subretinal Delivery of RGX-314 AAV8-anti-VEGF Fab Gene Therapy in NHP: Retinal Structure Over One Year
20182
9
Normal parameters of the full field ERG recorded with bipolar electrodes in Cynomolgus Macaque (Macaque fascicularis)
20171
10
Subretinal delivery of RGX-314 AAV8-anti-VEGF Fab gene therapy in NHP
20171
11
Safety of subretinal delivery of RGX-314 (AAV8-anti-VEGF Fab) in the non-human primate as assessed by full-field ERG
20181
12 20161

About Erin Bote

Erin Bote is a scholar working on Genetics, Molecular Biology, Epidemiology, Ophthalmology and Cellular and Molecular Neuroscience, having authored 12 papers that have together received 366 indexed citations. Recurring topics across this work include Virus-based gene therapy research (10 papers), Retinal Development and Disorders (4 papers), Retinal and Optic Conditions (3 papers), RNA Interference and Gene Delivery (3 papers), Herpesvirus Infections and Treatments (3 papers), Hemophilia Treatment and Research (2 papers), CAR-T cell therapy research (2 papers) and Neuroscience and Neural Engineering (1 paper). The work is most often cited by research in Genetics (211 citations), Ophthalmology (34 citations), Cellular and Molecular Neuroscience (68 citations), Molecular Biology (232 citations) and Genetics (33 citations). Erin Bote has collaborated with scholars based in United States and Jamaica. Frequent co-authors include James M. Wilson, Peter Bell, Rebecca Grant, Jean‐Pierre Louboutin, Christian Hinderer, Charles H. Vite, Hongwei Yu, Tamara Goode, Bryan Pukenas and Robert W. Hurst. Their work appears in journals such as Investigative Ophthalmology & Visual Science, Molecular Therapy — Methods & Clinical Development, Human Gene Therapy, Science Translational Medicine and Molecular Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact